Over the past decade, mouse models of cancer have come to resemble human disease much more closely than simple subcutaneous or orthotopic systems. Intervention strategies that work on these new model systems are more likely to have an impact clinically. We have shown recently that antiangiogenic stress imposed by loss of Id protein in endothelial progenitor cells results in dramatic central necrosis in breast tumors initiated in mice by overexpression of the her2/neu oncogene. Tumor cells remain viable at the periphery, perhaps via the hypoxic response pathway which allows the lesions to expand. Inhibition of this pathway by the inactivation of the Hif-1α chaperone Hsp90 in combination with antiangiogenic stress leads to the first reported complete regression of these aggressive breast tumors. © 2005 Cold Spring Harbor Laboratory Press.
Induction of complete regressions of oncogene-induced breast tumors in mice / Benezra, R.; Henke, E.; Ciarrocchi, A.; Ruzinova, M.; Solit, D.; Rosen, N.; Nolan, D.; Mittal, V.; De Candia, P.. - In: COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. - ISSN 0091-7451. - 70:0(2005), pp. 375-381. [10.1101/sqb.2005.70.006]
Induction of complete regressions of oncogene-induced breast tumors in mice
De Candia P.Ultimo
2005
Abstract
Over the past decade, mouse models of cancer have come to resemble human disease much more closely than simple subcutaneous or orthotopic systems. Intervention strategies that work on these new model systems are more likely to have an impact clinically. We have shown recently that antiangiogenic stress imposed by loss of Id protein in endothelial progenitor cells results in dramatic central necrosis in breast tumors initiated in mice by overexpression of the her2/neu oncogene. Tumor cells remain viable at the periphery, perhaps via the hypoxic response pathway which allows the lesions to expand. Inhibition of this pathway by the inactivation of the Hif-1α chaperone Hsp90 in combination with antiangiogenic stress leads to the first reported complete regression of these aggressive breast tumors. © 2005 Cold Spring Harbor Laboratory Press.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


